Clinical Trials Directory

Trials / Sponsors / Fujian Akeylink Biotechnology Co., Ltd.

Fujian Akeylink Biotechnology Co., Ltd.

Industry · 10 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingTo Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatit
Chronic Hepatitis b
Phase 32025-07-24
RecruitingA Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of
Chronic Hepatitis B
Phase 22023-12-26
CompletedDrug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
Healthy Participant
Phase 12023-05-12
UnknownFood Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants
COVID-19 Respiratory Infection
Phase 12023-05-04
UnknownPharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function
COVID-19 Pneumonia
N/A2023-02-10
CompletedEvaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets
Chronic Hepatitis b
Phase 22023-01-03
CompletedStudy of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
COVID-19 Pneumonia
Phase 2 / Phase 32022-12-19
CompletedPharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function
COVID-19 Pneumonia
Phase 12022-12-15
CompletedSafety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets
COVID-19
Phase 12022-10-01
UnknownSafety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets
Pharmacokinetics, Food Affect, Single Ascending Dose
Phase 12022-07-19